Pyonephrosis cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Harsh Vardhan Chawla, M.B.B.S.[2]

Cost-effectiveness of therapy

Given the significant morbidity and rapid mortality associated with pyonephrosis, and the low cost of safe and effective antibiotics, current pharmacotherapy in combination with urgent decompression to treat pyonephrosis is relatively cost-effective.^[1]

References

↑ Tamburrini S, Lugarà M, Iannuzzi M, Cesaro E, De Simone F, Del Biondo D; et al. (2021). “Pyonephrosis Ultrasound and Computed Tomography Features: A Pictorial Review”. Diagnostics (Basel). 11 (2). doi:10.3390/diagnostics11020331. PMC 7921924 Check |pmc= value (help). PMID 33671431 Check |pmid= value (help).

Template:WH Template:WS

[pmid33671431-1] Tamburrini S, Lugarà M, Iannuzzi M, Cesaro E, De Simone F, Del Biondo D; et al. (2021). “Pyonephrosis Ultrasound and Computed Tomography Features: A Pictorial Review”. Diagnostics (Basel). 11 (2). doi:10.3390/diagnostics11020331. PMC 7921924 Check |pmc= value (help). PMID 33671431 Check |pmid= value (help).

[1]

Pyonephrosis cost-effectiveness of therapy

Cost-effectiveness of therapy

References

Looking for the patient version?